La Trobe
Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition.pdf (2.59 MB)
Download file

Impact of HLA-DR antigen binding cleft rigidity on T cell recognition

Download (2.59 MB)
journal contribution
posted on 08.02.2021, 00:45 by C Szeto, JI Bloom, H Sloane, CA Lobos, J Fodor, D Jayasinghe, Demetra SM Chatzileontiadou, EJ Grant, AM Buckle, S Gras
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. The interaction between T cell receptor (TCR) and peptide (p)-Human Leukocyte Antigen (HLA) complexes is the critical first step in determining T cell responses. X-ray crystallographic studies of pHLA in TCR-bound and free states provide a structural perspective that can help understand T cell activation. These structures represent a static “snapshot”, yet the nature of pHLAs and their interactions with TCRs are highly dynamic. This has been demonstrated for HLA class I molecules with in silico techniques showing that some interactions, thought to stabilise pHLA-I, are only transient and prone to high flexibility. Here, we investigated the dynamics of HLA class II molecules by focusing on three allomorphs (HLA-DR1,-DR11 and-DR15) that are able to present the same epitope and activate CD4+ T cells. A single TCR (F24) has been shown to recognise all three HLA-DR molecules, albeit with different affinities. Using molecular dynamics and crystallographic ensemble refinement, we investigate the molecular basis of these different affinities and uncover hidden roles for HLA polymorphic residues. These polymorphisms were responsible for the widening of the antigen binding cleft and disruption of pHLA-TCR interactions, underpinning the hierarchy of F24 TCR binding affinity, and ultimately T cell activation. We expanded this approach to all available pHLA-DR structures and discovered that all HLA-DR molecules were inherently rigid. Together with in vitro protein stability and peptide affinity measurements, our results suggest that HLA-DR1 possesses inherently high protein stability, and low HLA-DM susceptibility.

Funding

This work was funded by the Australian National Health and Medical Research Council (NHMRC), E.J.G. is a NHMRC CJ Martin Fellow (#1110429), S.G. is a NHMRC SRF-A Fellow (#1159272).

History

Publication Date

01/10/2020

Journal

International Journal of Molecular Sciences

Volume

21

Issue

19

Article Number

7081

Pagination

(p. 1-19)

Publisher

Multidisciplinary Digital Publishing Institute (MDPI)

ISSN

1422-0067

Rights Statement

The Author reserves all moral rights over the deposited text and must be credited if any re-use occurs. Documents deposited in OPAL are the Open Access versions of outputs published elsewhere. Changes resulting from the publishing process may therefore not be reflected in this document. The final published version may be obtained via the publisher’s DOI. Please note that additional copyright and access restrictions may apply to the published version.